Table 2
Parameter | All | Non-endemic | Arsenic-endemic | p-value |
---|---|---|---|---|
Subjects (n) | 236 | 61 | 175 | |
Drinking water As (μg/L)b | ||||
Total subjects | 17.76 (15.16) | 0.76 (5.49) | 53.39 (7.90) | <0.001* |
Males | 13.28 (19.90) | 0.60 (4.96) | 40.22 (9.02) | <0.001* |
Females | 24.66 (13.97) | 0.98 (6.10) | 73.09 (6.52) | <0.001* |
p-value (between male & female groups) | 0.081* | 0.269* | 0.056* | |
Hair As (μg/g)b | ||||
Total subjects | 1.28 (4.43) | 0.25 (2.38) | 2.08 (3.54) | <0.001* |
Males | 1.08 (4.80) | 0.19 (2.15) | 1.99 (3.70) | <0.001* |
Females | 1.39 (3.99) | 0.36 (2.40) | 2.20 (3.38) | <0.001* |
p-value (between male & female groups) | 0.191* | <0.01* | 0.604* | |
Nail As (μg/g)b | ||||
Total subjects | 3.40 (3.53) | 0.96 (2.43) | 5.29 (2.96) | <0.001* |
Males | 3.19 (3.41) | 1.05 (2.32) | 4.73 (3.00) | <0.001* |
Females | 3.67 (3.78) | 0.85 (2.58) | 5.98 (2.98) | <0.001* |
p-value (between male & female groups) | 0.403* | 0.367* | 0.155* | |
Skin symptoms [n, (%)] | ||||
(+) symptom | 132 (55.90) | 0 (0.0) | 132 (75.40) | <0.001† |
(−) symptom | 104 (44.10) | 61 (100.0) | 43 (24.60) | |
DBP (mm Hg)a | ||||
Total subjects | 77.11 ± 11.84 | 71.97 ± 9.89 | 78.90 ± 11.96 | <0.001* |
Males | 76.73 ± 10.51 | 73.33 ± 8.26 | 77.95 ± 10.99 | <0.05* |
Females | 77.54 ± 13.21 | 70.36 ± 11.46 | 79.96 ± 12.93 | <0.01* |
p-value (between male & female groups) | 0.608* | 0.245* | 0.269* | |
SBP (mm Hg)a | ||||
Total subjects | 118.72 ± 18.01 | 111.18 ± 14.22 | 121.35 ± 18.48 | <0.001* |
Males | 116.56 ± 14.83 | 112.88 ± 10.91 | 117.88 ± 15.83 | 0.097* |
Females | 121.16 ± 20.83 | 109.18 ± 17.30 | 125.20 ± 20.45 | <0.001* |
p-value (between male & female groups) | 0.055* | 0.334* | <0.01* | |
Hypertension [n, (%)] | ||||
Total subjects | ||||
Yes | 32 (13.60) | 3 (4.90) | 29 (16.60) | <0.05† |
No | 204 (86.40) | 58 (95.10) | 146 (83.40) | |
Males | ||||
Yes | 10 (8.00) | 0 (0.0) | 10 (10.90) | <0.05† |
No | 115 (92.00) | 33 (100.0) | 82 (89.10) | |
Females | ||||
Yes | 22 (19.80) | 3 (10.70) | 19 (22.90) | 0.162† |
No | 89 (80.20) | 25 (89.30) | 64 (77.10) | |
p-value (between male & female groups) | <0.01† | 0.054† | <0.05† | |
LINE-1 Methylation level (%)a | ||||
Total subjects | 64.94 ± 2.12 | 65.67 ± 1.99 | 64.69 ± 2.12 | <0.01* |
Males | 65.21 ± 1.91 | 65.46 ± 2.24 | 65.12 ± 1.78 | 0.430* |
Females | 64.65 ± 2.33 | 65.92 ± 1.66 | 64.23 ± 2.38 | <0.01* |
p-value (between male & female groups) | <0.05* | 0.372* | <0.01* |
aMean ± SD. bGeometric mean (GSD) for log-transformed value
* p- and † p-values were obtained by independent sample t-test and Chi-square test, respectively